Published Date: 23 Aug 2024
Patients with terminal illness explore end-of-life options
Read Full NewsExtended-release buprenorphine injections increase the number of opioid-free days primarily via direct pathways and by suppressing need-related craving, a causal mediation analysis shows.
Moderate-to-severe fatty pancreas is independently linked to a higher risk for incident type 2 diabetes and chronic kidney disease.
1.
Checking PSA levels too soon after prostate cancer surgery can lead to overtreatment, study suggests
2.
Six breast texture patterns linked to higher risk of invasive cancer
3.
Biomarker Flags 10-Fold Recurrence Risk in Testicular Cancer
4.
For the treatment of paroxysmal nocturnal hemoglobinuria, the FDA has approved an oral factor B inhibitor.
5.
Firefighters who eat better can combat cancer.
1.
Managing High Potassium Levels: A Comprehensive Guide to Veltassa
2.
Breast Cancer Recovery: Fashion, Function, and Healing Beyond Scars
3.
Living with Shwachman-Diamond Syndrome: A Journey of Hope and Strength
4.
Breakthroughs in Oncology: Advances in Immunotherapy, Radiation & Precision Diagnostics
5.
Early-Onset GI Cancers: Screening, AI Innovations & Research Advances 2025
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Conclusion
2.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part II
3.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VII
4.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part I
5.
Navigating the Complexities of Ph Negative ALL - Part VIII
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation